Janux Therapeutics Inc (JANX)
55.80
+1.41
(+2.59%)
USD |
NASDAQ |
Nov 04, 16:00
57.98
+2.18
(+3.91%)
Pre-Market: 08:34
Janux Therapeutics Market Cap: 2.911B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.911B |
| November 01, 2024 | 2.837B |
| October 31, 2024 | 2.816B |
| October 30, 2024 | 2.919B |
| October 29, 2024 | 2.828B |
| October 28, 2024 | 2.836B |
| October 25, 2024 | 2.786B |
| October 24, 2024 | 2.781B |
| October 23, 2024 | 2.700B |
| October 22, 2024 | 2.754B |
| October 21, 2024 | 2.634B |
| October 18, 2024 | 2.610B |
| October 17, 2024 | 2.598B |
| October 16, 2024 | 2.577B |
| October 15, 2024 | 2.751B |
| October 14, 2024 | 2.574B |
| October 11, 2024 | 2.585B |
| October 10, 2024 | 2.463B |
| October 09, 2024 | 2.400B |
| October 08, 2024 | 2.344B |
| October 07, 2024 | 2.303B |
| October 04, 2024 | 2.348B |
| October 03, 2024 | 2.304B |
| October 02, 2024 | 2.267B |
| October 01, 2024 | 2.321B |
| Date | Value |
|---|---|
| September 30, 2024 | 2.370B |
| September 27, 2024 | 2.413B |
| September 26, 2024 | 2.432B |
| September 25, 2024 | 2.498B |
| September 24, 2024 | 2.534B |
| September 23, 2024 | 2.622B |
| September 20, 2024 | 2.619B |
| September 19, 2024 | 2.607B |
| September 18, 2024 | 2.521B |
| September 17, 2024 | 2.580B |
| September 16, 2024 | 2.602B |
| September 13, 2024 | 2.609B |
| September 12, 2024 | 2.427B |
| September 11, 2024 | 2.280B |
| September 10, 2024 | 2.375B |
| September 09, 2024 | 2.183B |
| September 06, 2024 | 2.152B |
| September 05, 2024 | 2.280B |
| September 04, 2024 | 2.320B |
| September 03, 2024 | 2.348B |
| August 30, 2024 | 2.451B |
| August 29, 2024 | 2.329B |
| August 28, 2024 | 2.306B |
| August 27, 2024 | 2.356B |
| August 26, 2024 | 2.420B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
269.99M
Minimum
Nov 09 2023
3.359B
Maximum
May 03 2024
1.000B
Average
643.19M
Median
Market Cap Benchmarks
| Dynavax Technologies Corp | 1.545B |
| Krystal Biotech Inc | 4.909B |
| Arcus Biosciences Inc | 1.423B |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Palatin Technologies Inc | 23.26M |
Market Cap Related Metrics
| PS Ratio | 180.68 |
| Price to Book Value | 4.426 |
| Price | 55.80 |
| Earnings Yield | -1.61% |